Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning

Improving productivity to reduce the cost of biologics manufacturing and ensure that therapeutics can reach more patients remains a major challenge faced by the biopharmaceutical industry. Chinese hamster ovary (CHO) cell lines are commonly prepared for biomanufacturing by single cell cloning post-t...

Full description

Bibliographic Details
Main Authors: Qin He, Matthew S. Rehmann, Jun Tian, Jianlin Xu, Luzmary Sabino, Erik Vandermark, Ziev Basson, Iris Po, Kathleen Bierilo, Gabi Tremml, Giovanni Rizzi, Erik F. Langsdorf, Nan-Xin Qian, Michael C. Borys, Anurag Khetan, Zheng-Jian Li
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Bioengineering
Subjects:
re-cloning
titer
biologics manufacturing
Chinese hamster ovary cells
cell culture platform
Online Access:https://www.mdpi.com/2306-5354/9/4/173

Internet

https://www.mdpi.com/2306-5354/9/4/173

Similar Items